Background: Gastric cancer is the fifth most common cancer and the third cause of global cancer mortality. CDX2 is an intestinal differentiation marker with prognostic value in gastric cancer and transcriptionally regulates the expression of glycoprotein A33 (GPA33) and liver intestine cadherin (LI-cadherin).
Methods: This study evaluated the clinical significance of the combined expression of CDX2 and its targets GPA33 and LI-cadherin in gastric cancer by fluorescence-based multiplex immunohistochemistry together with digital image analysis and chromogenic immunohistochemistry in 329 gastric cancer samples arranged in tissue microarrays. Additionally, publicly available RNA-seq expression data from 354 gastric cancer samples from the TCGA database were used to validate the immunohistochemistry results.
Results: Expression of the three markers (CDX2, GPA33, and LI-cadherin) was strongly correlated, defining an intestinal differentiation panel. Low or negative protein expression of the intestinal differentiation panel identified patients with particularly poor overall survival, irrespective of the methodology used, and was validated in the independent series at the RNA-seq level.
Conclusions: Expression of the intestinal differentiation panel (CDX2, GPA33, and LI-cadherin) defines a set of biomarkers with a strong biological rationale and favourable impact for prognostication of gastric cancer patients.
Keywords: Gastric cancer; Intestinal differentiation markers; Prognostic markers.
CDX2 regulates liver intestine-cadherin expression in normal and malignant colon epithelium and intestinal metaplasia.Gastroenterology. 2002 Nov;123(5):1565-77. doi: 10.1053/gast.2002.36598. Gastroenterology. 2002. PMID: 12404231
CDX2 co-localizes with liver-intestine cadherin in intestinal metaplasia and adenocarcinoma of the stomach.J Pathol. 2005 Apr;205(5):615-22. doi: 10.1002/path.1741. J Pathol. 2005. PMID: 15732140
Altered expression of a Li-cadherin in gastric cancer and intestinal metaplasia.Dig Dis Sci. 2007 Feb;52(2):536-42. doi: 10.1007/s10620-006-9316-9. Epub 2007 Jan 17. Dig Dis Sci. 2007. PMID: 17226075
Liver-intestine cadherin expression is associated with intestinal differentiation and carcinogenesis in intraductal papillary mucinous neoplasm.Pathobiology. 2012;79(2):107-14. doi: 10.1159/000334269. Epub 2012 Jan 27. Pathobiology. 2012. PMID: 22286087
131I-Labeled recombinant anti-glycoprotein A33 antibody single chain variable fragment fused to cytosine deaminase.2009 Jul 8 [updated 2009 Aug 12]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. Molecular Imaging and Contrast Agent Database (MICAD). 2004–2013. PMID: 20641233 Free Books & Documents. Review.